Filter
2610
Filtered Results: 2610
Text search:
COVID-19
Impact
Featured
Recommendations
277
New Publications
43
Language
Document type
Studies & Reports
1049
Guidelines
597
Strategic & Response Plan
291
Manuals
196
Fact sheets
196
Situation Updates
91
No document type
63
Training Material
41
Resource Platforms
32
Infographics
29
Brochures
13
Online Courses
7
Videos
5
Countries / Regions
Global
269
Latin America and the Carribbean
106
Africa
79
Brazil
74
Ukraine
65
Syria
60
Western and Central Europe
52
Middle East and North Africa
50
India
47
Russia
46
East and Southern Africa
45
Kenya
43
West and Central Africa
43
Congo, Democratic Republic of
42
Yemen
41
Germany
33
South–East Asia Region
33
Ethiopia
33
Mozambique
31
Eastern Europe and Central Asia
31
Venezuela
29
Nigeria
26
South Africa
25
South Sudan
25
Colombia
24
Haiti
22
Bangladesh
21
Chile
20
Malawi
20
Myanmar / Burma
18
Burkina Faso
17
Afghanistan
17
Argentina
17
Somalia
17
Senegal
16
Niger
16
Mali
16
Peru
15
Western Pacific Region
15
Sudan
15
Ghana
14
Central African Republic
14
Angola
14
Philippines
12
Uganda
12
Eastern Europe
12
Pakistan
12
Lebanon
11
Ecuador
11
Sierra Leone
10
Indonesia
10
Guinea-Bissau
9
Chad
9
Zambia
9
Cameroon
8
Moldova
8
Nepal
7
Thailand
7
Mexico
7
China
7
Rwanda
7
Cambodia
7
Tanzania
7
Jordan
7
Côte d’Ivoire / Ivory Coast
7
Bolivia
7
Vietnam
7
Palestine
7
Libya
7
Liberia
7
El Salvador
6
Kazakhstan
6
Laos
6
Zimbabwe
6
North America
6
Tunisia
6
Iraq
6
Jamaica
5
Spain
5
Namibia
5
Lesotho
4
Turkey
4
Congo-Brazzaville
4
Burundi
4
Malaysia
4
USA
4
Asia
4
Hungary
4
Paraguay
4
Portugal
4
Egypt
4
Honduras
4
Madagascar
4
Eswatini/ Swaziland
4
Guatemala
4
Tajikistan
3
Benin
3
Iran
3
Kyrgyzstan
3
Uzbekistan
3
Morocco
3
Mauritania
3
Guinea
3
Italy
3
Saudi Arabia
3
Turkmenistan
3
France
3
Papua New Guinea
3
Sri Lanka
3
North Korea
2
Timor Leste/ East Timor
2
Bulgaria
2
Mauritius
2
United Kingdom
2
Algeria
2
Belarus
2
Nicaragua
2
Djibouti
2
Romania
2
Poland
2
Botswana
2
North Macedonia
1
Gambia
1
Togo
1
Fiji
1
Vanuatu
1
Mongolia
1
Qatar
1
Armenia
1
Dominican Republic
1
Gabon
1
Japan
1
Norway
1
South Korea
1
Morocco
1
French Guyana
1
Israel
1
Slovakia
1
Greece
1
Georgia
1
Bhutan
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
1009
Public Health
142
Key Resources
131
Women & Child Health
100
Clinical Guidelines
99
Capacity Building
29
Pharmacy & Technologies
22
Annual Report MEDBOX
2
Toolboxes
COVID-19
1280
Planetary Health
192
Conflict
125
Mental Health
94
Health Financing Toolbox
89
Refugee
85
Caregiver
79
HIV
74
NCDs
61
Global Health Education
56
TB
52
Rapid Response
48
NTDs
45
AMR
41
Natural Hazards
29
Disability
24
Pharmacy
16
Malaria
11
Polio
8
Cholera
5
Ebola & Marburg
5
Social Ethics
4
Zika
3
Specific Hazards
1
As daily lives and communities are upended by COVID-19, concern is mounting that children’s exposure to violence may increase. Children with a history of abuse may find themselves even more vulnerable – both at home and online – and may experience more frequent and severe acts of violence. Oth...
The 'asks' have been prepared for private businesses to take concrete actions in the COVID19 pandemic.
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Les notes d’orientation décrivent les mesures essentielles que les décideurs aux niveaux national et infranational peuvent mettre en place concernant les aspects suivants : les tests de diagnostic de la COVID19, la prise en charge clinique de la COVID-19, la réalisation des cibles en matière ...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
Internally displaced persons (IDPs), refugees, migrants and returnees constitute a sizeable population in the WHO Eastern Mediterranean Region. There were 12 million refugees (half are Palestinians) and 13 million IDPs in the Region as of 2018. These populations are often vul...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
4 April 2020
This interim guidance on oxygen sources and distribution strategies for COVID-19 treatment has been adapted from WHO and UNICEF’s technical specifications and guidance for oxygen therapy devices, which is part of the WHO medical device technical series. This guidance is intended for ...
The checklist is aligned with, and builds upon, existing COVID-19-related WHO guidelines and is structured around protective measures related to: 1) hand hygiene and respiratory etiquette; 2) physical distancing; 3) use of masks in schools; 4) environmental cleaning and ventilation; and 5) respectin...
Right now, we are facing an unpredictable and highly dynamic situation as a global community. However, as we have seen from the solidarity, support and power of communities in the HIV epidemic and already in communities responding to the COVID-19 pandemic, the response must not be fear and stigma. W...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
People-centered approaches that help communities maintain protective behaviours and follow guidelines set out by public health and government agencies are more important than ever. The evidence is clear, communities play a role in preventing and controlling epidemics and they are best able to take a...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. WHO continues to support countries in adjusting COVID-19 strategies to reflect succ...
